Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-Q
Source: 0001731122-25-000258
Chunk: 164

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-Q
Item: Part I, Item 3
Chunk 164
---
.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities. 

None.

Item 4. Mine Safety Disclosures. 

Not applicable.

Item 5. Other Information.

Insider Trading Plans

During the quarter ended December 31, 2024, no director
or Section 16 officer adopted, modified, or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading
arrangement” (in each case, as defined in Item 408(a) of Regulation S-K).

39

Item 6. Exhibits.

Exhibits required by Item 601 of Regulation S-K:

    Exhibit No.
     
    Description 

     2.1
     
    Second Amendment to Stock Purchase Agreement, dated February 13, 2024, by and among Renovaro Inc., GEDi Cube Intl Ltd., the sellers party thereto and Yalla Yalla Ltd. (incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed with the SEC on February 14, 2024)

    3.1 
     
    Certificate of Incorporation, as amended (incorporated by reference to Exhibit 3.1 to the Company’s Form 10-Q filed with the SEC on February 14, 2024)

    3.2
     
    Amended and Restated Bylaws (incorporated herein by reference to Exhibit 3.1 to Form 8-K filed with the SEC on May 24, 2024)

    10.1
     
    Employment Agreement by and between David Weinstein and Renovaro Inc., dated as of October 14, 2024. (incorporated herein by reference to Exhibit 10.2 to the Company’s Form 10-Q filed with the SEC on November 14, 2024)

    10.2**
     
    Employment Agreement by and between Nathen Fuentes and Renovaro Inc., dated as of January 6, 2025.

    10.3**
     
    Amended and Restated Employment Agreement by and between Maurice van Tilburg and GEDI CUBE B.V., dated as of February 4, 2025.

    31.1**
     
    Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule